Page last updated: 2024-10-28

hypericin and Leishmaniasis

hypericin has been researched along with Leishmaniasis in 1 studies

Leishmaniasis: A disease caused by any of a number of species of protozoa in the genus LEISHMANIA. There are four major clinical types of this infection: cutaneous (Old and New World) (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), mucocutaneous (LEISHMANIASIS, MUCOCUTANEOUS), and visceral (LEISHMANIASIS, VISCERAL).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lopera, AA1
Velásquez, AMA1
Clementino, LC1
Robledo, S1
Montoya, A1
de Freitas, LM1
Bezzon, VDN1
Fontana, CR1
Garcia, C1
Graminha, MAS1

Other Studies

1 other study available for hypericin and Leishmaniasis

ArticleYear
Solution-combustion synthesis of doped TiO
    Journal of photochemistry and photobiology. B, Biology, 2018, Volume: 183

    Topics: Animals; Anthracenes; Cell Survival; DNA Damage; Iron; Leishmania; Leishmaniasis; Macrophages, Perit

2018